Impact of perioperative α1-antagonists on postoperative urinary retention in orthopaedic surgery: meta-analysis

Author:

Huang Yun-Ting1,Chang Yu2,Kang Yi-No3,Huang Chin-Hsuan3,Lin Yu-Shiuan4,Wu Jeffrey5,Chi Kuan-Yu36,Chen Wei-Cheng5

Affiliation:

1. Department of Anesthesiology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University , Tainan , Taiwan

2. Department of Surgery, Section of Neurosurgery Department, National Cheng Kung University Hospital, National Cheng Kung University , Tainan , Taiwan

3. Department of Education, Center for Evidence-Based Medicine, Taipei Medical University Hospital , Taipei , Taiwan

4. Department of Emergency Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation , New Taipei City , Taiwan

5. Department of Orthopaedics, Shuang Ho Hospital, Taipei Medical University , Taipei , Taiwan

6. Department of Internal Medicine, Taipei Medical University Hospital , Taipei , Taiwan

Abstract

AbstractBackgroundPostoperative urinary retention (POUR) is a common complication following orthopaedic surgery. Previous studies attempted to establish the preventative role of α1-antagonist in POUR in the general surgical population; however, there is still no consensus regarding its use in orthopaedic surgery due to limited evidence.MethodsElectronic databases of Cochrane Library, Embase, MEDLINE, and ClinicalTrials.gov were searched by two independent investigators from inception to 1 March 2022 to identify relevant randomized clinical trials. Two reviewers independently completed a critical appraisal of included trials by using the Cochrane Risk of Bias tool version 2.0 and extracted data from included articles. Risk of POUR was summarized as risk ratio (RR) with 95 per cent confidence intervals (c.i.). Mean difference (MD) was used for meta-analysis of continuous outcomes.ResultsFive randomized clinical trials involving 878 patients (α1-antagonist, 434; placebo, 444) undergoing hip/knee arthroplasty and spine surgeries were included. One study was assessed as high risk of bias from the randomization process and was excluded from the final meta-analysis. There was no difference in the risk of POUR between patients taking α1-antagonist and the placebo in arthroplasty (RR, 0.64; 95 per cent c.i., 0.36 to 1.14) and in spine surgeries (RR, 1.03; 95 per cent c.i., 0.69 to 1.55). There was no difference in length of stay (MD, −0.14 days; 95 per cent c.i., −0.33 to 0.05). Use of α1-antagonist was associated with a higher risk of adverse events (RR, 1.97; 95 per cent c.i., 1.27 to 3.06), with a composite of dizziness, light-headedness, fatigue, altered mental status, and syncope being the most commonly reported symptoms.ConclusionIn patients undergoing spinal surgery and joint arthroplasty, routine administration of perioperative α1-antagonist does not decrease risk of POUR but does increase perioperative dizziness, light-headedness, and syncope.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Reference41 articles.

1. Risk factors for postoperative urinary retention following elective spine surgery: a meta-analysis;Chang;Spine J,2021

2. Postoperative urinary retention in modern rapid recovery total joint arthroplasty;Bracey;J Am Acad Orthop Surg,2022

3. Postoperative urinary retention. I. Incidence and predisposing factors;Tammela;Scand J Urol Nephrol,1986

4. Postoperative urinary retention: anesthetic and perioperative considerations;Baldini;Anesthesiology,2009

5. Urethral instrumentation and deep sepsis in total hip replacement;Wroblewski;Clin Orthop Relat Res,1980

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3